Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Level Biotechnology Inc. (3118) Financial Statements

Level Biotechnology Inc. Financial Overview

Level Biotechnology Inc.'s market cap is currently NT$993.06M. The company's EPS TTM is NT$2.35; its P/E ratio is 12.83; and it has a dividend yield of 7.30%. Level Biotechnology Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 736.59MNT$ 731.35MNT$ 660.61MNT$ 593.01MNT$ 677.28M
Gross ProfitNT$ 244.31MNT$ 237.13MNT$ 219.54MNT$ 202.59MNT$ 232.50M
Operating IncomeNT$ 83.55MNT$ 75.26MNT$ 67.55MNT$ 64.90MNT$ 78.96M
EBITDANT$ 106.00MNT$ 102.62MNT$ 98.70MNT$ 93.00MNT$ 105.06M
Net IncomeNT$ 79.70MNT$ 64.81MNT$ 62.91MNT$ 58.47MNT$ 68.18M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 210.34MNT$ 252.78MNT$ 467.41MNT$ 463.50MNT$ 472.95M
Total AssetsNT$ 866.80MNT$ 827.11MNT$ 822.67MNT$ 812.53MNT$ 787.62M
Total DebtNT$ 7.98MNT$ 12.68MNT$ 13.50MNT$ 12.73MNT$ 13.36M
Net DebtNT$ -202.36MNT$ -240.10MNT$ -453.90MNT$ -450.76MNT$ -459.59M
Total LiabilitiesNT$ 286.63MNT$ 267.19MNT$ 273.20MNT$ 270.13MNT$ 242.78M
Stockholders' EquityNT$ 580.18MNT$ 559.91MNT$ 549.47MNT$ 542.40MNT$ 544.84M
Cash Flow
Free Cash FlowNT$ 26.94MNT$ -159.58MNT$ 62.54MNT$ 58.33MNT$ 146.79M
Operating Cash FlowNT$ 59.61MNT$ 64.10MNT$ 70.21MNT$ 65.07MNT$ 155.95M
Investing Cash FlowNT$ -38.93MNT$ -216.10MNT$ -10.90MNT$ -10.19MNT$ -8.79M
Financing Cash FlowNT$ -63.12MNT$ -62.70MNT$ -55.40MNT$ -64.34MNT$ -54.52M

Currency in TWD

Level Biotechnology Inc. Earnings and Revenue History

0300M600M900M5 %7.5 %10 %12.5 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Level Biotechnology Inc. Liabilities to Assets

0400M800M1.2B24 %28 %32 %36 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Level Biotechnology Inc. Cash Flow

-300M-200M-100M0100M200M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Level Biotechnology Inc. Forecast EPS vs Actual EPS

0.30.40.50.60.70.80.9Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >